Many of the studies used liquid biopsy based on ddPCR technology to predict treatment response or track disease progression
With Bio-Rad's expertise, EMBL aims to expand its training portfolio of innovative methodologies for young scientists
First commercially available droplet digital PCR solution for detecting pathogenic STEC
Learn which applications are most common and more from our latest PCR survey results
New solution empowers scientists to precisely evaluate the efficiency of their experiment in less time and at lower cost than with any other method
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature